Suche Orphan Drug
Weitere Suchoptionen
132 Ergebnis(se)
Wirkstoff(e)
- (1'R,6'R)-3-(benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione
- (2R,3S)-2-(4-cyclopentylaminophenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid(4-methyl-3-trifluoromethylphenyl)amide
- (Z)-3-(3-(3,5-bis(Trifluormethyl)phenyl-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylhydrazid
- -[4-Aminobutanoic acid-glycyl-L-glutaminyl-L-arginyl-L-.alpha.-glutamyl-L-threonyl-L-prolyl-L-.alpha.-glutamylglycyl-L-alanyl-L-.alpha.-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-L-aspartyl](cyclo 1-Dgamma17)
- 2,2'-{2-[(1R)-1-({[(2,5- Dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4,4-diyl}Acetessigsäure
- 2-(2-chlorphenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-c]pyridin-3,6(2H, 5H)-dion
- 2-[4-Methoxy-3-(2-m-benzyl-ethoxy)-benzoylamino]-indan-2-carbonsäure
- 3-Pentylbenzeneacetic acid sodium salt
- 4-{(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl}benzoic acid-hydrogen chloride(1/1)
- 5'-ASCSASTSCSASGSTSCSTSGSASUSASASGSCSTSA-3'
- Adalimumab
- Adult human bone-marrow-derived, ex-vivo-expanded, pooled allogeneic mesenchymal stromal cells
- Antagonist of the complement 5a receptor
- Anti-von Willebrand Aptamer
- Apremilast
- Auf die A1-Domäne des humanen von Willebrand Faktors gerichteter Nanobody
- Autologous adipose tissue-derived mesenchymal stem cells
- Aviptadil
- Bardoxolone methyl
- Birtamimab
- Bosentan
- Budesonide (oral use)
- Cannabidiol
- Carboxypyrrolidin-hexanoylpyrrolidincarboxylat
- Chimeric fibril-reactive IgG1k monoclonal antibody 11-1F4
- Colchicin
- Complement factor H
- Danicopan
- Daratumumab
- Defibrotid
- Eculizumab
- Eprodisate
- Everolimus
- Fraktion autologer, mononukleärer Zellen aus dem Knochenmark
- Fresolimumab
- Gevokizumab
- Gusperimus trihydrochloride
- Humaner rekombinanter Minibody gegen den Komplementfaktor C5
- Immunoglobulin G-degrading enzyme of Streptococcus pyogenes
- Immunoglobulin vom menschen
- In einer porcinen Gelatine-Matrix kultivierte, allogene Endothelzellen aus der Aorta
- Iodine (123I) Serum Amyloid P
- L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser
- L-cystine bis(N-methylpiperazide)
- Lanreotide acetate
- Levamisolhydrochlorid
- Lixivaptan
- Menadione sodium bisulfite
- Mepolizumab
- Mirdametinib
- N-(3,4-dihydroxyphenyl)-3,4-dihydroxybenzamide
- Natives bovines Hautkollagen Typ I
- Natriumthiosulfat
- Nintedanib
- Nitroglycerin
- Paquinimod
- Peptide 144 TGF-beta1-inhibitor (TSLDASIIWAMMQN)
- Poly(oxy-1,2-ethanediyl),.alpha.-hydro-.omega.-hydroxy-,15,15'-diester with N-acetyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-.alpha.-aspartyl-L-tryptophylglycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-L-threonyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-N6-carboxy-L-lysinamide cyclic (2.fwdarw.12)-(disulfide)
- Pomalidomid
- Propagermanium
- Protein-based delivery vector carrying a DNA payload encoding an RNA-guided nuclease that targets stx genes of Shiga toxin-producing Escherichia coli
- Recombinant human ADAMTS-13
- Recombinant human monoclonal antibody against mannan-binding lectin-associated serine protease-2
- Recombinant human monoclonal antibody to human IL-1beta of the IgG1/K class
- Recombinant humanised anti-human interleukin-1 beta monoclonal antibody
- Rekombinante Variante von Interferon-alpha-2b , wobei der Restbestand von menschlichem Gluatamat an Position 41 von Glutamin ersetzt wird
- Rekombinante humane Pankreas-Elastase Typ I
- Rekombinanter monoklonaler Antikörper gegen die humane Serum Amyloid P Komponente
- Resunab
- Rilonacept
- Riociguat
- Rituximab
- Romilkimab
- S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)
- Selumetinib
- Setmelanotide
- Single stranded, chemically modified oligonucleotide that binds to and inhibits the function of micro RNA-21
- Sirolimus (Rapamycin)
- Stickstoffmonoxid
- Synthetic peptide L-cysteine, L-cysteinylglycyl-L-glutaminyl-L-arginyl-L-.alpha.-glutamyl-L-threonyl-L-prolyl-L-.alpha.-glutamylglycyl-L-alanyl-L-.alpha.-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-, cyclic (1.fwdarw.17)-disulfide
- Tergurid
- Tiopronin
- Tocilizumab
- Tolvaptan
- Treprostinil diethanolamine (oral use)
- Tripotassium citrate monohydrate and potassium hydrogen carbonate
- Vascular endothelial growth factor-D gene in an adenoviral vector for use with a collagen collar
- autologous adipose tissue-derived stromal vascular fraction cells
- caprine hyperimmune serum against HIV lysate
- equine immunoglobulin F(ab')2 fragments targeting Shiga toxin
- florbetaben (18F)
- human engineered monoclonal antibody specific for transforming growth factor ß1 (TGF- ß1)
- humanised IgG1K monoclonal antibody against interferon beta
- siponimob
- ziritaxestat
Handelsname(n)
- ACTEMRA
- AFINITOR
- BLITZIMA
- CABLIVI
- COLCHICINE HOUDE
- COLCHIMAX
- COLCRYS
- DARZALEX
- DISULONE
- Darzalex Faspro
- ENDOXAN
- EPIDIOLEX
- EPIDYOLEX
- ILARIS
- JINARC
- KINERET
- KOSELUGO
- MABTHERA
- NUCALA
- OFEV
- OTEZLA
- Octagam 10%
- RILONACEPT REGENERON
- RITEMVIA
- RITUXAN
- RITUZENA
- RIXATHON
- RIXIMYO
- ROACTEMRA
- Ruxience
- SOLIRIS
- STAYVEER
- THIOLA
- TRACLEER
- TRUXIMA
- Tavneos
- VOTUBIA